DEX administration reduces C-reactive protein (CRP) and procalcitonin levels in patients with sepsis requiring mechanical ventilation, improves albumin levels, and alleviates inflammation (Ohta et al., 2020). The gene discussed is ALB; the disease is Sepsis.